BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11602626)

  • 21. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
    Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
    J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-15 amplifies the pathogenic properties of CD4+CD28- T cells in multiple sclerosis.
    Broux B; Mizee MR; Vanheusden M; van der Pol S; van Horssen J; Van Wijmeersch B; Somers V; de Vries HE; Stinissen P; Hellings N
    J Immunol; 2015 Mar; 194(5):2099-109. PubMed ID: 25617471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activating NK-cell receptors co-stimulate CD4(+)CD28(-) T cells in patients with rheumatoid arthritis.
    Fasth AE; Björkström NK; Anthoni M; Malmberg KJ; Malmström V
    Eur J Immunol; 2010 Feb; 40(2):378-87. PubMed ID: 19904767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CD4+ T-cell subset lacking expression of the CD28 costimulatory molecule is expanded and shows a higher activation state in multiple sclerosis.
    Pinto-Medel MJ; García-León JA; Oliver-Martos B; López-Gómez C; Luque G; Arnáiz-Urrutia C; Orpez T; Marín-Bañasco C; Fernández O; Leyva L
    J Neuroimmunol; 2012 Feb; 243(1-2):1-11. PubMed ID: 22261542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous interferon-β-inducible gene expression and interferon-β-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis.
    Börnsen L; Romme Christensen J; Ratzer R; Hedegaard C; Søndergaard HB; Krakauer M; Hesse D; Nielsen CH; Sorensen PS; Sellebjerg F
    PLoS One; 2015; 10(3):e0118830. PubMed ID: 25738751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients.
    Broux B; Pannemans K; Zhang X; Markovic-Plese S; Broekmans T; Eijnde BO; Van Wijmeersch B; Somers V; Geusens P; van der Pol S; van Horssen J; Stinissen P; Hellings N
    J Autoimmun; 2012 Feb; 38(1):10-9. PubMed ID: 22123179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis.
    Astier AL; Meiffren G; Freeman S; Hafler DA
    J Clin Invest; 2006 Dec; 116(12):3252-7. PubMed ID: 17099776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
    Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C
    J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-15 preferentially enhances functional properties and antigen-specific responses of CD4+CD28(null) compared to CD4+CD28+ T cells.
    Alonso-Arias R; Moro-García MA; Vidal-Castiñeira JR; Solano-Jaurrieta JJ; Suárez-García FM; Coto E; López-Larrea C
    Aging Cell; 2011 Oct; 10(5):844-52. PubMed ID: 21635686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells.
    Park W; Weyand CM; Schmidt D; Goronzy JJ
    Eur J Immunol; 1997 May; 27(5):1082-90. PubMed ID: 9174596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of costimulation in autoimmune demyelination.
    Racke MK; Ratts RB; Arredondo L; Perrin PJ; Lovett-Racke A
    J Neuroimmunol; 2000 Jul; 107(2):205-15. PubMed ID: 10854658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
    Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis.
    Waldrop SL; Davis KA; Maino VC; Picker LJ
    J Immunol; 1998 Nov; 161(10):5284-95. PubMed ID: 9820501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD28 costimulation is crucial for the development of spontaneous autoimmune encephalomyelitis.
    Oliveira-dos-Santos AJ; Ho A; Tada Y; Lafaille JJ; Tonegawa S; Mak TW; Penninger JM
    J Immunol; 1999 Apr; 162(8):4490-5. PubMed ID: 10201986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD28 costimulation is required not only to induce IL-12 receptor but also to render janus kinases/STAT4 responsive to IL-12 stimulation in TCR-triggered T cells.
    Park WR; Park CS; Tomura M; Ahn HJ; Nakahira Y; Iwasaki M; Gao P; Abe R; Hamaoka T; Fujiwara H
    Eur J Immunol; 2001 May; 31(5):1456-64. PubMed ID: 11465102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.
    Klaus SJ; Pinchuk LM; Ochs HD; Law CL; Fanslow WC; Armitage RJ; Clark EA
    J Immunol; 1994 Jun; 152(12):5643-52. PubMed ID: 7515910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells.
    Witsch EJ; Peiser M; Hutloff A; Büchner K; Dorner BG; Jonuleit H; Mages HW; Kroczek RA
    Eur J Immunol; 2002 Sep; 32(9):2680-6. PubMed ID: 12207353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
    Khattri R; Auger JA; Griffin MD; Sharpe AH; Bluestone JA
    J Immunol; 1999 May; 162(10):5784-91. PubMed ID: 10229811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.